149 related articles for article (PubMed ID: 9264374)
1. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL.
Clausen PA; Athanasiou M; Chen Z; Dunn KJ; Zhang Q; Lautenberger JA; Mavrothalassitis G; Blair DG
Leukemia; 1997 Aug; 11(8):1224-33. PubMed ID: 9264374
[TBL] [Abstract][Full Text] [Related]
2. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells.
Athanasiou M; Mavrothalassitis G; Sun-Hoffman L; Blair DG
Leukemia; 2000 Mar; 14(3):439-45. PubMed ID: 10720139
[TBL] [Abstract][Full Text] [Related]
3. ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation.
Athanasiou M; Blair DG; Mavrothalassitis G
Anticancer Res; 2003; 23(3A):2143-53. PubMed ID: 12894589
[TBL] [Abstract][Full Text] [Related]
4. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
Feriotto G; Nastruzzi C; Barbieri R; Gambari R
Blut; 1988 Jul; 57(1):25-30. PubMed ID: 3164639
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype.
Athanasiou M; Clausen PA; Mavrothalassitis GJ; Zhang XK; Watson DK; Blair DG
Cell Growth Differ; 1996 Nov; 7(11):1525-34. PubMed ID: 8930402
[TBL] [Abstract][Full Text] [Related]
7. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
9. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1.
Lam LT; Ronchini C; Norton J; Capobianco AJ; Bresnick EH
J Biol Chem; 2000 Jun; 275(26):19676-84. PubMed ID: 10783395
[TBL] [Abstract][Full Text] [Related]
10. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation in erythroleukemic K562 cells by gamma-irradiation.
Schwenke K; Peterson HP; Wangenheim KH; Feinendegen LE
Leuk Res; 1995 Dec; 19(12):955-61. PubMed ID: 8632665
[TBL] [Abstract][Full Text] [Related]
12. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
13. Hemin-induced erythroid differentiation of human myeloleukemia K562 cell line and its modification by bioresponse modifiers.
Nakajima O; Iwasaki S; Hashimoto Y
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):115-34. PubMed ID: 9074796
[TBL] [Abstract][Full Text] [Related]
14. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S
Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094
[TBL] [Abstract][Full Text] [Related]
15. Role of Ets-1 in erythroid differentiation.
Marziali G; Perrotti E; Ilari R; Lulli V; Coccia EM; Mazzeo S; Kühn LC; Testa U; Battistini A
Blood Cells Mol Dis; 2002; 29(3):553-61. PubMed ID: 12547252
[TBL] [Abstract][Full Text] [Related]
16. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
17. The Ets-transcription factor family in embryonic development: lessons from the amphibian and bird.
Remy P; Baltzinger M
Oncogene; 2000 Dec; 19(55):6417-31. PubMed ID: 11175358
[TBL] [Abstract][Full Text] [Related]
18. Mouse models in the study of the Ets family of transcription factors.
Bartel FO; Higuchi T; Spyropoulos DD
Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Moore DC; Carter DL; Studzinski GP
J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
[TBL] [Abstract][Full Text] [Related]
20. The Ets family contains transcriptional activators and repressors involved in angiogenesis.
Lelièvre E; Lionneton F; Soncin F; Vandenbunder B
Int J Biochem Cell Biol; 2001 Apr; 33(4):391-407. PubMed ID: 11312108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
